The newly acquired ELITech Molecular Diagnostics business also contributed, positioning Bruker as an emerging infectious disease specialist in the in-vitro diagnostics (IVD) market. Within Bruker’s ...

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...

M&T Bank Corp lifted its stake in Bruker Co. (NASDAQ:BRKR – Free Report) by 303.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,870 shares of the medical ...

On Tuesday, 11 March 2025, Bruker Corporation (NASDAQ: BRKR) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic outlook amidst a mix of challenges and ...

Stock analysts at Zacks Research upped their Q4 2025 EPS estimates for Bruker in a research report issued to clients and investors on Thursday, March 6th. Zacks Research analyst R. Department now ...

On Tuesday, 11 March 2025, Bruker Corporation (NASDAQ: BRKR) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic outlook amidst a mix of challenges and ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

In the growing quest to extend not just lifespan, but also health span, these at-home hot boxes are gathering momentum ...

timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications. All that is missing are your ...

Where to start? Failure analysis is a systematic process that uses electrical characterization, physical analysis, and ...